Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris

Clinical trial NCT00306878 · COMPLETED

Trial details

NCT number: NCT00306878
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Psoriasis Vulgaris

Start date: 1995-08-01
Primary completion: 1997-05-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.